Curis reported $-15097000 in EBITDA for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Amgen AMGN:US $ 3341M 185M
AstraZeneca AZN:LN 4187M 687M
Bristol Myers Squibb BMY:US $ 5772M 404M
Chimerix CMRX:US $ -24.75M 14.76M
Curis CRIS:US $ -15.1M 2.57M
Eli Lilly And LLY:US $ 3005.6M 161.6M
Epizyme EPZM:US $ -49.63M 0.33M
Exelixis EXEL:US $ 87.73M 30.84M
Gilead Sciences GILD:US $ 3422M 1947M
GlaxoSmithKline GSK:LN 3120M 1062M
Merk MRK:US $ 6179M 492M
Mirati Therapeutics MRTX:US $ -183.59M 12.92M
Novartis NOVN:VX SF 4552M 346M
Pfizer PFE:US $ 11182M 4046M
Spectrum Pharmaceuticals SPPI:US $ -13.99M 22.79M
Takeda 4502:JP Y 150655M 139878M
Tg Therapeutics TGTX:US $ -66.8M 26.07M
Verastem VSTM:US $ -16.95M 0.47M
Xoma XOMA:US $ -2063000 32.43M
YTE INCY:US $ 144.1M 9.29M
Ziopharm Oncology ZIOP:US $ -8.4M 1.21M